{"schema_version":"secwatch.filing_event.v1","accession":"0001401708-24-000051","form_type":"8-K","ticker":null,"cik":"0001401708","company_name":"NS Wind Down Co., Inc.","filed_at":"2024-04-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.253201+00:00","generated_at":"2026-06-03T15:23:57.801307+00:00","sec_items":["1.01","1.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"NanoString to be acquired by Bruker for ~$392.6M; prior stalking-horse deal terminated","bullets":["Bruker to acquire substantially all NanoString assets for ~$392.6M cash, plus assumption of certain liabilities.","Transaction follows competitive auction; represents ~78% improvement over stalking-horse bid by Patient Square Capital.","NanoString to pay Patient Square $6.6M break-up fee and up to $3.3M expense reimbursement for terminated prior agreement.","Sale expected to close in early-May 2024, subject to Bankruptcy Court approval and other conditions.","NanoString filed for Chapter 11 in Feb 2024; acquisition will conclude the restructuring process."],"urls":{"canonical":"https://secwatch.observer/filing/0001401708-24-000051","json":"https://secwatch.observer/filing/0001401708-24-000051.json","markdown":"https://secwatch.observer/filing/0001401708-24-000051.md","text":"https://secwatch.observer/filing/0001401708-24-000051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401708/000140170824000051/0001401708-24-000051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401708/000140170824000051/nstg-20240417.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T15:23:57.801307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"435629d3af3c7299c56d2a625455f92967cd4707","claim":"NS Wind Down Co., Inc. entered into Bruker Asset Purchase Agreement with Bruker Corporation valued at $392,555,000 (effective 2024-04-17).","evidence_excerpt":"On April 17, 2024, the Company and Bruker entered into an Asset Purchase Agreement (the “Bruker Asset Purchase Agreement”) to sell substantially all of the assets of the Company and its subsidiaries (the “Business”) for a cash purchase price of $392,555,000 (the “Purchase Price”) along with Bruker’s assumption of certain liabilities of the Business (including liabilities related to all outstanding intellectual property litigation).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170824000051/0001401708-24-000051-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Bruker Corporation"},{"label":"Value","value":"$392,555,000"},{"label":"Effective","value":"2024-04-17"}],"fact_type":"material_agreement"},{"claim_id":"c530ca62faf47131aa8378b2650f1ac9e280bcd3","claim":"NS Wind Down Co., Inc. terminated Patient Square Asset Purchase Agreement with an affiliate of Patient Square Capital (effective 2024-04-17).","evidence_excerpt":"On April 17, 2024, as a result of the outcome of the Auction, the Patient Square Asset Purchase Agreement was terminated.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170824000051/0001401708-24-000051-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"an affiliate of Patient Square Capital"},{"label":"Effective","value":"2024-04-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}